News from ISGlobal
A new study led by ISGlobal has found that paracetamol (acetaminophen), which is used extensively during pregnancy, has a strong association with autism spectrum symptoms in boys and with attention-related and hyperactivity symptoms in both genders.
The findings were published today in the International Journal of Epidemiology. This is the first study of its kind to report an independent association between the use of this drug in pregnancy and autism spectrum symptoms in children. It is also the first study to report different effects on boys and girls. Comparing persistently exposed to unexposed children, the study has found a 30% increase in the risk of detriment to some attention functions, and an increase of autism spectrum symptoms in boys.
Researchers in Spain recruited 2,644 mother-child pairs in a birth cohort study during pregnancy. 88% were evaluated when the child was one year old, and 79.9% were evaluated when they were five years old. Mothers were asked about their use of paracetamol during pregnancy and the frequency of use was classified as never, sporadic, or persistent.
43% of children evaluated at age one and 41% assessed at age five were exposed to paracetamol at some point during the first 32 weeks of pregnancy. When assessed at age five, exposed children had close to 40% higher risk of presenting hyperactivity or impulsivity symptoms. Persistently exposed children in particular showed poorer performance on a computerised test measuring inattention, impulsivity and visual speed processing. Boys also showed two more autism spectrum symptoms when persistently exposed to paracetamol, compared to non-exposed boys. Authors explained that although they measured symptoms and not diagnoses, an increase in the number of symptoms that a child presents can affect him or her, even if they are not severe enough to warrant a clinical diagnosis of a neurodevelopmental disorder.